Other Species / Isoforms
  TGFBR2 iso1 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S31
IPPHVPKSDVEMEAQ
0 1
TGFBR2 (human) IPPHVQKSVNNDMIV S31
TGFBR2 iso2 (human) IPPHVQKsDVEMEAQ S31
TGFBR2 (mouse) IPPHVPKSVNSDVMA S31
TGFBR2 iso1 (mouse) IPPHVPKSDVEMEAQ S31
TGFBR2 (rat) IPPHVPKSVNSDLMA S31
S238
PRKLMDFSDNCAIIL
1 0
TGFBR2 (human) TRKLMEFsEHCAIIL S213
TGFBR2 iso2 (human) TRKLMEFSEHCAIIL S238
TGFBR2 (mouse) PRKLMDFSDNCAIIL S213
TGFBR2 iso1 (mouse) PRKLMDFSDNCAIIL S238
TGFBR2 (rat) PRKLMDFSDNCAIIL S213
S250
IILEDDRsDIssTCA
Upstream
1 0
Treatment
  • TGF-beta
TGFBR2 (human) IILEDDRSDISSTCA S225
TGFBR2 iso2 (human) IILEDDRSDISSTCA S250
TGFBR2 (mouse) IILEDDRSDISSTCA S225
TGFBR2 iso1 (mouse) IILEDDRsDIssTCA S250
TGFBR2 (rat) IILEDDRSDISSTCA S225
S253
EDDRsDIssTCANNI
Upstream
1 0
Treatment
  • TGF-beta
TGFBR2 (human) EDDRSDISSTCANNI S228
TGFBR2 iso2 (human) EDDRSDISSTCANNI S253
TGFBR2 (mouse) EDDRSDISSTCANNI S228
TGFBR2 iso1 (mouse) EDDRsDIssTCANNI S253
TGFBR2 (rat) EDDRSDISSTCANNI S228
S254
DDRsDIssTCANNIN
Upstream
1 0
Treatment
  • TGF-beta
TGFBR2 (human) DDRSDISSTCANNIN S229
TGFBR2 iso2 (human) DDRSDISSTCANNIN S254
TGFBR2 (mouse) DDRSDISSTCANNIN S229
TGFBR2 iso1 (mouse) DDRsDIssTCANNIN S254
TGFBR2 (rat) DDRSDISSTCANNIN S229
Y284
KGRFAEVYKAKLKQN
2 0
TGFBR2 (human) KGRFAEVyKAKLKQN Y259
TGFBR2 iso2 (human) KGRFAEVYKAKLKQN Y284
TGFBR2 (mouse) KGRFAEVYKAKLKQN Y259
TGFBR2 iso1 (mouse) KGRFAEVYKAKLKQN Y284
TGFBR2 (rat) KGRFAEVYKAKLKQN Y259
Y309
KIFPYEEySSWKTEK
Downstream
3 0
Effects on Biological Processes:
  • cell growth, altered
  • cytoskeletal reorganization
TGFBR2 (human) KIFPYEEyASWKTEK Y284
TGFBR2 iso2 (human) KIFPYEEYASWKTEK Y309
TGFBR2 (mouse) KIFPYEEYSSWKTEK Y284
TGFBR2 iso1 (mouse) KIFPYEEySSWKTEK Y309
TGFBR2 (rat) KIFPYEEYSSWKTEK Y284
Y361
AKGNLQEYLTRHVIS
3 0
TGFBR2 (human) AKGNLQEyLTRHVIS Y336
TGFBR2 iso2 (human) AKGNLQEYLTRHVIS Y361
TGFBR2 (mouse) AKGNLQEYLTRHVIS Y336
TGFBR2 iso1 (mouse) AKGNLQEYLTRHVIS Y361
TGFBR2 (rat) AKGNLQEYLTRHVIS Y336
S377
EDLRKLGSSLARGIA
0 1
TGFBR2 (human) EDLRKLGsSLARGIA S352
TGFBR2 iso2 (human) EDLRKLGSSLARGIA S377
TGFBR2 (mouse) EDLRKLGSSLARGIA S352
TGFBR2 iso1 (mouse) EDLRKLGSSLARGIA S377
TGFBR2 (rat) EDLRKLGSSLARGIA S352
S434
LRLDPTLsVDDLANS
1 5
TGFBR2 (human) LRLDPTLsVDDLANs S409
TGFBR2 iso2 (human) LRLDPTLSVDDLANS S434
TGFBR2 (mouse) LRLDPTLSVDDLANS S409
TGFBR2 iso1 (mouse) LRLDPTLsVDDLANS S434
TGFBR2 (rat) LRLDPTLSVDDLANS S409
S441
sVDDLANSGQVGTAR
1 0
TGFBR2 (human) sVDDLANsGQVGTAR S416
TGFBR2 iso2 (human) SVDDLANSGQVGTAR S441
TGFBR2 (mouse) SVDDLANSGQVGTAR S416
TGFBR2 iso1 (mouse) sVDDLANSGQVGTAR S441
TGFBR2 (rat) SVDDLANSGQVGTAR S416
Y449
GQVGTARYMAPEVLE
3 9
TGFBR2 (human) GQVGTARyMAPEVLE Y424
TGFBR2 iso2 (human) GQVGTARYMAPEVLE Y449
TGFBR2 (mouse) GQVGTARYMAPEVLE Y424
TGFBR2 iso1 (mouse) GQVGTARYMAPEVLE Y449
TGFBR2 (rat) GQVGTARYMAPEVLE Y424
T470
NVESFKQTDVYSMAL
0 1
TGFBR2 (human) NVESFKQtDVYSMAL T445
TGFBR2 iso2 (human) NVESFKQTDVYSMAL T470
TGFBR2 (mouse) NVESFKQTDVYSMAL T445
TGFBR2 iso1 (mouse) NVESFKQTDVYSMAL T470
TGFBR2 (rat) NMESFKQTDVYSMAL T445
Y495
AVGEVKDYEPPFGSK
1 0
TGFBR2 (human) AVGEVKDyEPPFGSK Y470
TGFBR2 iso2 (human) AVGEVKDYEPPFGSK Y495
TGFBR2 (mouse) AVGEVKDYEPPFGSK Y470
TGFBR2 iso1 (mouse) AVGEVKDYEPPFGSK Y495
TGFBR2 (rat) AVGEVKDYEPPFGSK Y470
S511
REHPCVEsMKDSVLR
0 2
TGFBR2 (human) REHPCVEsMKDNVLR S486
TGFBR2 iso2 (human) REHPCVESMKDNVLR S511
TGFBR2 (mouse) REHPCVESMKDSVLR S486
TGFBR2 iso1 (mouse) REHPCVEsMKDSVLR S511
TGFBR2 (rat) REHPCVESMKDNVLR S486
S573
LEHPERLSGRsCsQE
0 13
TGFBR2 (human) LEHLDRLsGRsCsEE S548
TGFBR2 iso2 (human) LEHLDRLSGRSCSEE S573
TGFBR2 (mouse) LEHPERLSGRSCSQE S548
TGFBR2 iso1 (mouse) LEHPERLSGRsCsQE S573
TGFBR2 (rat) LEHPDRLsGRSCSQE S548
S576
PERLSGRsCsQEKIP
Upstream
1 6
Treatment
  • insulin
  • LY294002
  • TGF-beta
TGFBR2 (human) LDRLsGRsCsEEKIP S551
TGFBR2 iso2 (human) LDRLSGRSCSEEKIP S576
TGFBR2 (mouse) PERLSGRSCSQEKIP S551
TGFBR2 iso1 (mouse) PERLSGRsCsQEKIP S576
TGFBR2 (rat) PDRLsGRSCSQEKIP S551
S578
RLSGRsCsQEKIPED
Upstream
1 14
Treatment
  • insulin
  • TGF-beta
TGFBR2 (human) RLsGRsCsEEKIPED S553
TGFBR2 iso2 (human) RLSGRSCSEEKIPED S578
TGFBR2 (mouse) RLSGRSCSQEKIPED S553
TGFBR2 iso1 (mouse) RLSGRsCsQEKIPED S578
TGFBR2 (rat) RLsGRSCSQEKIPED S553
S587
EKIPEDGSLNTTK__
0 2
TGFBR2 (human) EKIPEDGsLNTtK__ S562
TGFBR2 iso2 (human) EKIPEDGSLNTTK__ S587
TGFBR2 (mouse) EKIPEDGSLNTTK__ S562
TGFBR2 iso1 (mouse) EKIPEDGSLNTTK__ S587
TGFBR2 (rat) EKIPEDGSLNTTK__ S562
T591
EDGSLNTTK______
0 1
TGFBR2 (human) EDGsLNTtK______ T566
TGFBR2 iso2 (human) EDGSLNTTK______ T591
TGFBR2 (mouse) EDGSLNTTK______ T566
TGFBR2 iso1 (mouse) EDGSLNTTK______ T591
TGFBR2 (rat) EDGSLNTTK______ T566